Journal of Neuroscience Research 2014-12-01

L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.

Yong Wang, Hui Sheng Wang, Tao Wang, Chen Huang, Jian Liu

Index: J. Neurosci. Res. 92(12) , 1733-45, (2014)

Full Text: HTML

Abstract

L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID) is the most common complication of standard L-DOPA therapy for Parkinson's disease experienced by most parkinsonian patients. LID is associated with disruption of dopaminergic homeostasis in basal ganglia following L-DOPA administration. Norepinephrine (NE) is another important catecholaminergic neurotransmitter that is also believed to be involved in the pathogenesis of LID. This study compared NE release in the ipsilateral sensorimotor striatum of dyskinetic and nondyskinetic 6-hydroxydopamine-lesioned hemiparkinsonian rats treated chronically with L-DOPA. After L-DOPA injection, the time-course curves of NE levels in the sensorimotor striatum were significantly different between dyskinetic and nondyskinetic rats. Several metabolic kinetic parameters of NE levels were also differentially expressed between the two groups. In comparison with nondyskinetic rats, the ΔCmax of NE was significantly higher in dyskinetic rats, whereas Tmax and t1/2 of NE were significantly shorter. Intrastriatal perfusion of NE into the lesioned sensorimotor striatum revealed a moderate dyskinesia in dyskinetic rats, which was similar to the dyskinetic behavior after L-DOPA administration. The L-DOPA-related dyskinetic behavior was inhibited significantly by a further pretreatment of noradrenergic neurotoxin N-​(2-​chloroethyl)​-​N-​ethyl-​2-​bromobenzylamine or intrastriatal administration of the α2 -adrenoceptor antagonist idazoxan, accompanied by significant changes in metabolic kinetic parameters of NE in the sensorimotor striatum. The results provide evidence to support the correlation between abnormal NE neurotransmission and the induction of LID and suggest that the aberrant change of the quantitative and temporal releasing of NE in the sensorimotor striatum might play an important role in the pathogenesis of LID.© 2014 Wiley Periodicals, Inc.

Related Compounds

Structure Name/CAS No. Articles
Hydrogen bromide Structure Hydrogen bromide
CAS:10035-10-6
sodium chloride Structure sodium chloride
CAS:7647-14-5
Benserazide hydrochloride Structure Benserazide hydrochloride
CAS:14919-77-8
Calcium chloride Structure Calcium chloride
CAS:10043-52-4
Levodopa Structure Levodopa
CAS:59-92-7
SODIUM CHLORIDE-35 CL Structure SODIUM CHLORIDE-35 CL
CAS:20510-55-8
Desipramine hydrochloride Structure Desipramine hydrochloride
CAS:58-28-6
calcium chloride dihydrate Structure calcium chloride dihydrate
CAS:10035-04-8
L-3,4-Dihydroxyphenylalanine Methyl ester hydrochloride Structure L-3,4-Dihydroxyphenylalanine Methyl ester hydrochloride
CAS:1421-65-4